PATENT CLAIM ANALYSIS

Application Number: 15861248
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "222200"]

Abstract:
This invention relates to the prophylactic and/or therapeutic application of antimicrobials that are, for example, administered orally as a delayed release formulation designed to release the drug to the distal small intestine and/or colon in high quantities and density, as a method for the prevention and/or treatment of infections in the colon.

Claim (Index 18):
A composition for oral administration to a patient for treating a condition in the gastrointestinal tract of the patient, the composition comprising a taurolidine core contained within a decayable delivery vehicle, wherein the decayable delivery vehicle shields the taurolidine core from premature hydrolyzation of the taurolidine as the composition moves from the mouth of the patient to the distal small intestine or the colon of the patient and releases the taurolidine for hydrolyzation in the distal small intestine or the colon of the patient.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.4359
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13701372', '13441780', '12594542', '15410448', '12594553']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7298327023726852
- 35 USC 102 Novelty (BERT): 0.4936608038273221
- Combined Prediction Score: 0.7062155125181488
- Mean Citation Score: 195.744696
- Max Citation Score: 202.02228
- Similarity Product: 137.91669270601273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test